🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

RecruitingNCT05727540

The Cohort Study of Uveitis Patients

🏥 Zhongshan Ophthalmic Center, Sun Yat-sen University📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05736965

A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia

🏥 Shanghai Tong Ren Hospital📍 19 sites📅 Started Feb 2023View details ↗
Phase 2, PHASE3RecruitingNCT05749822

Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis

👨‍⚕️ Ying Han, Xijing Hospital, Air Force Military Medical Universit📍 12 sites📅 Started Feb 2023View details ↗
RecruitingNCT05952583

Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation

🏥 Leiden University Medical Center📍 6 sites📅 Started Feb 2023View details ↗
NARecruitingNCT07149714

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

👨‍⚕️ Dmitry Pevzner, MD, National Medical Research Center for Cardiology, Ministry of Health of Russian Federation📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05817214

Cadonilimab Plus Anlotinib for R/M/P Cervical Cancer

👨‍⚕️ Hui Qiu, Ph.D., Wuhan University📍 1 site📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT05558124

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

👨‍⚕️ Onyee Chan, MD, Moffitt Cancer Center📍 1 site📅 Started Feb 2023View details ↗
Phase 1, PHASE2Enrolling by InvitationNCT05614531

Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients with Spinal Muscular Atrophy Type 1

🏥 Guangzhou Jiayin Biotech Ltd📍 2 sites📅 Started Feb 2023View details ↗
RecruitingNCT05521529

Cushing's Syndrome Before and After Treatment (CORRECT)

👨‍⚕️ Jens Otto Lunde Jørgensen, Professor, AARHUS UNIVERSITY HOSPITAL, Medical Research Laboratory📍 1 site📅 Started Feb 2023View details ↗
Phase 3RecruitingNCT05707442

Stent Implantation Versus Medical Therapy for Idiopathic IntracraniaL Hypertension (SIMPLE)

👨‍⚕️ Dapeng Mo, MD, Beijing Tiantan Hospital📍 1 site📅 Started Feb 2023View details ↗
NARecruitingNCT05637294

Effect of Night-time and Full-time Splinting for Carpal Tunnel Syndrome

👨‍⚕️ Teemu Karjalainen, Tampere University Hospital📍 6 sites📅 Started Feb 2023View details ↗
NARecruitingNCT05694689

Randomized Trial of Enteral Vitamin D Supplementation in Infants < 28 Weeks Gestational Age or <1000 Grams Birth Weight

👨‍⚕️ Sunil Jain, MD, The University of Texas Medical Branch📍 1 site📅 Started Feb 2023View details ↗
NARecruitingNCT05241990

Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care

👨‍⚕️ Geetanjali Chander, MD, Johns Hopkins University📍 3 sites📅 Started Feb 2023View details ↗
RecruitingNCT05681962

Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy

👨‍⚕️ Federico Longhini, MD, Magna Graecia University📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05809869

Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma

👨‍⚕️ Victor Ho-Fun Lee, MD, The University of Hong Kong📍 1 site📅 Started Feb 2023View details ↗
NARecruitingNCT05615584

Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

🏥 University Hospital, Montpellier📍 1 site📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT05683418

A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors

👨‍⚕️ Zelanna Goldberg, MD, Totus Medicines📍 18 sites📅 Started Feb 2023View details ↗
Phase 1RecruitingNCT06307249

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

👨‍⚕️ Nehman Makdissy, Professor, Lebanese University📍 2 sites📅 Started Feb 2023View details ↗
EARLY_Phase 1RecruitingNCT05188118

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

👨‍⚕️ Che-Kai Tsao, Investigator📍 1 site📅 Started Feb 2023View details ↗
Phase 2RecruitingNCT05139719

A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients

🏥 Sunshine Lake Pharma Co., Ltd.📍 1 site📅 Started Feb 2023View details ↗
← PreviousPage 427 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →